A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics
Advanced Drug Delivery Reviews · 2023-10 · 201 · 115052
DOI: 10.1016/j.addr.2023.115052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-10. Verfasst von Sheyda Ranjbar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, USA. Hauptthemen laut MEDLINE: High-Throughput Screening Assays. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, National Institutes of Health.
Abstract (Originalsprache)
Small interfering RNAs (siRNAs) are among the most promising therapeutic platforms in many life-threatening diseases. Owing to the significant advances in siRNA design, many challenges in the stability, specificity and delivery of siRNA have been addressed. However, safety concerns and dose-limiting toxicities still stand among the reasons for the failure of clinical trials of potent siRNA therapies, calling for a need of more comprehensive understanding of their potential mechanisms of toxicity. This review delves into the intrinsic and delivery related toxicity mechanisms of siRNA drugs and takes a holistic look at the safety failure of the clinical trials to identify the underlying causes of toxicity. In the end, the current challenges, and potential solutions for the safety assessment and high throughput screening of investigational siRNA and delivery systems as well as considerations for design strategies of safer siRNA therapeutics are outlined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, USA.
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, USA. Electronic address: xiuling.lu@uconn.edu.
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institutes of Health
Zitieren
APA
Ranjbar, S., Zhong, X. B., Manautou, J., & Lu, X. (2023). A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics. Advanced Drug Delivery Reviews, 201, 115052. https://doi.org/10.1016/j.addr.2023.115052
Vancouver
Ranjbar S, Zhong XB, Manautou J, Lu X. A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics. Advanced Drug Delivery Reviews. 2023;201:115052. doi:10.1016/j.addr.2023.115052
BibTeX
@article{Ranjbar2023,
author = {Ranjbar, Sheyda and Zhong, Xiao-Bo and Manautou, José and Lu, Xiuling},
title = {A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics},
journal = {Advanced Drug Delivery Reviews},
year = {2023},
volume = {201},
pages = {115052},
doi = {10.1016/j.addr.2023.115052}
}
EUVIMED